Saving lives is indeed a much bigger priority and yes he's

New Post Public Reply Private Reply Replies (0) Message Board
DJknows LveGun-TakeCannoli #24498
481
Saving lives is indeed a much bigger priority and yes he's likely giving it his all especially now with CV but there's a PR firm in Red Chip and they can connect reporters (who I believe are likely calling them from throughout the country and beyond) to any one of the physicians working with/for CytoDyn (although I realize not many) to do an interview.

Regarding Red Chip , they must still be involved as this morning's PR had them putting it out... which means they are the ones writing it at the direction of company officials (likely Dr. Pourhassan). And I wonder whether they are passing their PRs by the FDA although may not be necessary (I just don't know the FDA process normally and particularly with this pandemic).

In any case, today's news is astounding and should be welcomed by all... of course patients... but I'm particularly thinking of the medical community dealing with COVID-19 because it could keep them healthy to help patients... as well as giving hope to all people.

I pray CytoDyn is able to produce the quantities quickly. And it doesn't matter that there are other companies (albeit not as good as CytoDyn apparently) that have drugs (although sound not as efficient as Leronlimab ) on the scene because the world need is so great and saving lives is immediately necessary that all the real help should be welcomed.

I suspect being able to actually administer Leronlimab starting today, may mean results could come in even quicker than two weeks. I realize it may take longer but we are in 'emergency' and unprecedented times... COVID-19 is NEW and we are dealing with it NOW ... unlike the 1957 flu outbreak or 1968 flu pandemic or 1918 or or or ....

And don't forget the original 7-10 patients, one of whom has already been taken off respirator and one released from hospital. I hope we get an update on each and every one of those 10.

Also, I believe the trial in today's PR could be like the trial within yesterday's PR which said they're testing 75 patients in up to 10 hospitals in the U.S. To me, that means in the 'hotspots' like New York and California and who knows where else.

And CytoDyn could easily make the international scene as we heard yesterday in Italy and the U.K. and maybe wherever needed/wanted and possible ... 150+ countries are now dealing with COVID-19, right?

https://www.cdc.gov/coronavirus/2019-ncov/cas...d-map.html

Please forgive lengthy post and stay safe!




Very best to all with CYDY !



CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Succession Planning in Turmoil: Only 42% Ready

Updated Category News Views 5

Diving into the Succession Crisis in Finance Succession planning in the financial advisory space is like retirement planning for the rest of us—everyone knows it's crucial, yet too many put it off. Despite the looming retirement wave and desperate interest from the younger cohort, a staggering 42% of financial advisors are still without a documented succession game...

Continue Reading
The Chemical Industry and EPA: A Broken System?

Updated Category News Views 6

Decades of an Unchecked Revolving Door The Environmental Protection Agency (EPA) and chemical manufacturers—a dance that’s been going on for what seems like forever. But not in the way you might hope. We're talking about a revolving door where execs and lobbyists waltz into regulatory chairs while regulators slide into cushy industry gigs. Wisner Baum LLP, a stickler...

Continue Reading
AI-Driven Lumi Transforms Car Dealership Interactions

Updated Category News Views 7

Lumi: Changing the Car Buying Game Picture this: You're browsing for a new car, head filled with specifics like towing capacity, price points, and trim options. Usually, such queries would send you bouncing around the web, but Lectrium's Lumi promises to keep the questioning—and decision-making—right on the dealership's page. In a move set to shake up the game,...

Continue Reading
Machine Grabs Prime Dallas Property Amid Apartment Boom

Updated Category News Views 4

Dallas' Hot Market and Machine's Bold Move Well, well, looks like Machine Investment Group's been busy flexing its real estate muscles, bagging a 490-unit gem in North Dallas—your typical, no-frills off-market grab. We’re talking 75 West, nestled in a juicy infill spot, and it’s catching eyes like gold dust in a pan. You don't need me to tell you North Dallas ain't...

Continue Reading
K-Beauty Takes Front Stage at Target Beauty Studio

Updated Category News Views 5

Making Waves in the U.S. with K-Beauty SUNGBOON EDITOR and Milk Touch just rolled into Target Beauty Studio, making a splash in the world of K-beauty. From ingredients that boast serious benefits to playful cosmetics that let you express yourself, these brands are shaking up American beauty routines in a big way. Ingredient-Focused Skincare for Every American Face...

Continue Reading
Sean Trahan Joins Citrin Cooperman: New Tax Lead

Updated Category News Views 7

Citrin Cooperman's Strategic Tax Move If there's one phrase that can spark a debate at a financial water cooler, it's 'transfer pricing.' Today, Citrin Cooperman is throwing its hat further into that ring with the appointment of Sean Trahan as head of their new Transfer Pricing and Value Chain Optimization Practice. This isn't just another reshuffling of office...

Continue Reading
HTX's Strategic Moves in Pakistan: A Crypto Frontier

Updated Category News Views 6

Paving the Way: HTX's Journey in Pakistan Rolling into the Pakistan cryptocurrency scene isn't just a 'walk in the park' for HTX—it's more like traversing a new frontier with an open map. This isn’t some hit-and-run operation; HTX is strategizing for a long haul in one of the liveliest digital market arenas in South Asia. Gathering steam with community AMAs and an X...

Continue Reading
Dr. Desi Bartlett Teams Up with Glo for Perimenopause Focus

Updated Category News Views 4

Glo Taps Top Wellness Expert for Women's Health Initiative In an industry brimming with wellness voices, it's rare to find one that marries scholarly acumen with authentic, personal teaching. Yet, this is precisely what Dr. Desi Bartlett brings to the table as she partners with Glo to offer new fitness programming specifically targeting women facing perimenopause and...

Continue Reading
FutureVault's AI Agents: Transforming Financial Workflows

Updated Category News Views 4

Revolutionizing Financial Operations: FutureVault's AI Approach In the dizzying whirlwind of financial services, the launch of FutureVault AI Agents is a game-changer for document management. This isn't some half-baked tool; it's a full-fledged overhaul of how compliance and operations should tick in the modern age. We've all seen it—a paper trail tangled across systems...

Continue Reading
Leapora's Taskeen: Redefining Task Accountability

Updated Category News Views 5

AI's Impact on Workplace Task Management In today’s whirlwind of AI-generated output, transparency is not just a luxury; it’s a necessity. AI systems churn out work that can appear polished but often lacks substance. This doesn't just create headaches; it triggers a ticking bomb in the regulatory department. According to a 2025 survey from Stanford and BetterUp Labs,...

Continue Reading

Top 5 Most Recently Viewed Articles

Ascendis Pharma Reports Q2 2024 Results and Positive Outlook

Updated Category News Views 78

Ascendis Pharma Reports Mixed Q2 Results Ascendis Pharma A/S (NASDAQ: ASND) has unveiled its financial results for the second quarter of 2024, revealing a mix of achievements and hurdles. A significant highlight of this quarter was the U.S. approval of YORVIPATH for the treatment of adult hypoparathyroidism. This marks a major milestone as it represents the company's...

Continue Reading
Analyzing New Zealand's Economic Growth and Monetary Policy Shifts

Updated Category News Views 135

New Zealand’s Economic Growth Overview New Zealand's latest growth figures present a significant turning point for a nation that has been adjusting to the impacts of substantial monetary easing. The economy showed a quarterly expansion of 1.1%, bouncing back after a contraction of 1.0% previously. This growth not only exceeded expectations, which were around 0.9%, but...

Continue Reading
Eli Lilly's Competitive Landscape in the Pharmaceuticals Sector

Updated Category News Views 688

Exploring Eli Lilly's Impact on the Pharmaceuticals Sector In the dynamic and competitive world of pharmaceuticals, understanding the role of companies like Eli Lilly & Co. (NYSE: LLY) is crucial for investors and stakeholders alike. This article offers a detailed comparative analysis of Eli Lilly's performance against its main competitors, focusing on key financial...

Continue Reading
Veriff Welcomes Tech Visionary Ott Kaukver to Its Board

Updated Category News Views 165

Veriff Expands Its Board with Industry Expertise Veriff, an innovative identity verification company known for its AI-native technology, recently appointed Ott Kaukver to its Board of Directors. This significant move illustrates the company’s determination to enhance trust in online identities globally. Kaukver, recognized for his role as the former CTO of Twilio and...

Continue Reading
University of Phoenix's New Initiative Promotes Responsible AI Use

Updated Category News Views 154

University of Phoenix Launches Center for AI Resources University of Phoenix has taken a significant step towards empowering its students and faculty by launching the Center for AI Resources. This initiative is designed to equip learners with essential knowledge for navigating the increasingly complex landscape of generative AI (GenAI). The Center serves as a...

Continue Reading